Sodium Iodide I 131 Diagnostic Capsule
Product Images NDC 65174-461

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sodium Iodide I 131 Diagnostic (NDC 65174-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Draximage Inc., Dba Jubilant Radiopharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Capsule 3.7 (Image1)

Label for Sodium Iodide I 131 Diagnostic, 100 mCi/1 capsule, oral dosage form by Jubilant DraxImage Inc. The label provides capsule activity of 3.7 MBq (100 µCi), total activity of 18.5 MBq (500 µCi) for 5 capsules, expiration info, radioactive material caution, and dosage/storage instructions. Capsules are gray.*

FDA Label Image

Capsule 3.7 (Image2)

Label for Sodium Iodide I 131 Diagnostic Oral Capsules, USP, 100 mCi strength by Jubilant DraxImage Inc. The label includes lot number, activity per capsule (3.7 MBq), number of capsules (5), total activity (18.5 MBq), expiry information, storage instructions (15 to 30°C), yellow capsule color indication, and a caution for radioactive material.*

FDA Label Image

Capsule 3.7 (Image3)

Sodium Iodide I 131 Diagnostic oral capsule label showing a strength of 3.7 MBq (100 µCi) per capsule and package count of 5 capsules. The label provides calibration and expiry details, specifies the capsule color as orange, and includes caution for radioactive material. The labeler is Jubilant DraxImage Inc., based in Kirkland, Quebec, Canada.*

FDA Label Image

Capsule 3.7 (Image4)

Sodium Iodide I 131 Diagnostic 100 mCi/1 capsule label includes dosage form as capsule and route as oral. The label provides details on activity per capsule (3.7 MBq or 100 µCi), package count (5 capsules), total activity (18.5 MBq or 500 µCi), expiry, and storage instructions (between 15 and 30°C). It highlights that the capsules are pink and includes caution about radioactive material. The labeler is Jubilant DraxImage Inc., based in Kirkland, Québec, Canada.*

FDA Label Image

Capsule 3.7 (Image5)

Label for Sodium Iodide I 131 Diagnostic oral capsule, USP, diagnostic strength 100 mCi. The label includes dosage activity, capsule count (5 capsules), calibration date, and storage instructions (15 to 30°C). It also notes the capsule color as green and identifies Jubilant DraxImage Inc. as the labeler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.